loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 208784 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 TEVA PHARMS USA (2)

filter

01 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL (2)

filter

01 RX (2)

filter

01 LANSOPRAZOLE (2)

filter

01 No (2)

URL Supplier Web Content
TABLET, ORALLY DIS...
30MG
2017-09-21
208784
LANSOPRAZOLE
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, ORALLY DIS...
15MG
2017-09-21
208784
LANSOPRAZOLE
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 208784

Looking for FDA Orange Book APPLICATION 208784 2

19

Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is LANSOPRAZOLE, with a corresponding application number 208784.

Regulatory Information RX

With a dosage strength 30MG

Dosage Form Route TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; ORAL

Reference Listed Drug No

Approved since 2017-09-21

Therapeutic Equivalence (TE) Code AB

18

Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is LANSOPRAZOLE, with a corresponding application number 208784.

Regulatory Information RX

With a dosage strength 15MG

Dosage Form Route TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; ORAL

Reference Listed Drug No

Approved since 2017-09-21

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY